ROSE RAY: Open Payments
NPI 1699958884 · DELAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$447 in 19 payments from 5 companies in 2025. Trend: 2023 $1,331 · 2024 $462 · 2025 $447
Food & beverage: $447
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $196 |
| Janssen Biotech, Inc. | 3 | $182 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $25 |
| Gilead Sciences, Inc. | 1 | $24 |
| GENZYME CORPORATION | 1 | $20 |
Products named: TREMFYA, SKYRIZI, RINVOQ, LINZESS, XIFAXAN, DUPIXENT, CREON.
Industry payments across FL — which companies pay providers there.
